How to Track Your Peptide Progress
Human perception is poor at detecting slow change and excellent at confirming what it expects. That combination is why most people never actually find out whether a compound did anything — and why measurement is the whole game.
This guide covers how to establish a baseline, choose metrics that match the compound, separate real change from normal variation, and decide in advance what would count as a result. It is educational only and not a substitute for advice from a qualified healthcare professional. Sources are listed at the end.
Here is the pattern that plays out constantly. Someone starts a compound, feels sharper in week one, tells a friend it is working, keeps buying it for eight months, and at no point has a single piece of information that would distinguish a real effect from having expected one.
That is not a failure of intelligence. It is what happens when you ask a human to detect a 4% change in something noisy, from memory, while invested in the outcome. The fix is not to try harder. It is to write things down before you start.
Why Perception Isn't Enough
Three things work against you, and they compound.
Expectation produces real effects
Novelty and anticipation genuinely improve how you feel, particularly in the first two weeks and particularly for subjective outcomes like energy, mood and focus. It fades. It is also indistinguishable from the real thing without a comparison point.
Memory rewrites the baseline
Asked how you felt six weeks ago, you reconstruct it from how you feel now. This makes improvement feel larger than it was and makes plateaus invisible.
The signal is small and the noise isn't
Most effects worth having are gradual. Day-to-day variation in weight, strength, sleep and mood is often larger than the weekly change you are trying to detect.
None of this means subjective experience is worthless — for something like sleep quality or joint pain it is the outcome that matters. It means subjective experience needs the same treatment as any other measurement: recorded at the time, on a consistent scale, against a starting point you wrote down before you had a stake in the answer.
Setting a Baseline
The single highest-value thing on this page, and the one most often skipped because it delays the exciting part by a fortnight.
Two weeks minimum before the first dose. Longer for noisy metrics — four weeks if you are tracking anything that varies with your training cycle, menstrual cycle, or workload. You are not just recording a number; you are learning how much your number normally moves when nothing is happening. Without that, you cannot tell later whether a change is real.
What a baseline actually tells you
Suppose you weigh yourself daily for two weeks and the readings span 2.4 kg with no trend. You have just learned that a 1 kg change means nothing, and that you will need several weeks of averages before any real movement is visible. Now suppose your grip strength varies by 3 kg across the same period — a 2 kg improvement in month two is inside your own noise. That is information you cannot get any other way, and it stops you drawing conclusions your data cannot support.
If you have not yet settled on a compound, do this while you decide — our guide to choosing your first peptide covers that half. Record the conditions alongside the numbers: your training volume, your typical sleep, whether you are dieting, what else you take. Those are the things that will change without you noticing and quietly explain your results.
Matching Metric to Compound
Different mechanisms produce different observable signatures on different timescales. Tracking the wrong thing, or checking too early, produces a false negative — which is how people abandon something that was working and escalate the dose on something that never would.
| Compound class | Worth measuring | Realistic timescale |
|---|---|---|
| GH-axis peptides | IGF-1 on bloodwork, waist circumference, sleep duration and quality, morning body weight trend, fasting glucose | Bloodwork at 6–8 weeks; body composition over months |
| GLP-1 compounds | Weekly average weight, waist, a daily appetite rating, protein intake, plus grip or a strength lift to catch lean-mass loss | Appetite within days; weight trend over 4–8 weeks |
| Healing and repair | Pain on a fixed 0–10 scale at a fixed time, range of motion measured the same way, a specific functional task you can time or count | 2–6 weeks, and confounded by natural healing |
| Cognitive and mood | A repeatable timed task, deep-work minutes, a daily 1–5 rating taken at the same hour, sleep as a confounder | 2–4 weeks; expect week one to mislead |
| Sleep-related | Time in bed vs time asleep, wake count, a morning refreshment rating. Wearable data is useful for trends, not for absolute stage accuracy | 2–3 weeks of averages |
| Metabolic | Fasting glucose, HbA1c, lipids, liver enzymes. Largely invisible without bloodwork | HbA1c reflects roughly 3 months, so retest no sooner |
Most abandoned protocols are abandoned before the metric being watched could have moved.
Signal vs Noise
The average adult's body weight moves by roughly 1 to 2 kg over a few days from fluid shifts, glycogen, food volume and stool alone. Nothing biological has changed. If you weigh yourself on a Tuesday and again the following Tuesday, you have measured mostly hydration.
This is why weekly averages beat weekly weigh-ins, and why a single reading is never evidence.
Holding conditions constant
- Same time, same state. Weight first thing, after the bathroom, before eating or drinking. A strength test at the same point in your session, not whenever you feel like it.
- Same instrument. One scale, one tape measure, one lab. Switching mid-protocol introduces a step change you will misread as an effect.
- Average, don't sample. Take a reading most days and compare weekly averages. This is the single biggest improvement most people can make.
- Change one thing at a time. Starting a compound the same week you change your training block means you will never know which did what.
- Photos on a schedule. Same room, same light, same time of day, same poses, same day of the week. Photos taken casually are worse than none — the lighting difference will convince you of something that isn't there.
Bloodwork That Means Something
For anything touching hormones or metabolism, blood tests are the part you cannot substitute with attention. You cannot feel a change in fasting glucose, and by the time you can, it is not a small change any more.
The IGF-1 example, because it explains the principle
People sometimes want to test growth hormone directly. That does not work: GH is released in pulses and fluctuates with food, stress, exercise and sleep, so a single blood draw tells you almost nothing about your average exposure.
IGF-1 is the standard proxy. It is more stable than GH and reflects average GH activity, which is why endocrinology guidelines recommend serum IGF-1 as the biomarker for guiding growth hormone dose adjustments, with the target being the age-adjusted reference range rather than a maximum. Clinical practice is to start low and titrate upward against IGF-1 specifically to avoid the side effects that come from overshooting.
The general lesson
Test the thing that is stable and downstream, not the thing that pulses. And test at a consistent point relative to your dosing — with longer-acting compounds, the day you draw blood can change the reading substantially, which means an inconsistent schedule produces a trend that is entirely an artefact of your timing.
What is commonly monitored
This is a description of what clinicians typically watch, not a prescription — which panel is appropriate for you is a conversation with a doctor who knows your history.
- On GH-axis compounds: IGF-1, fasting glucose, and often HbA1c, thyroid function and lipids. Reduced insulin sensitivity is the recognised class effect worth watching — see common side effects for the wider picture.
- On metabolic and GLP-1 compounds: HbA1c, fasting glucose, lipids, liver enzymes.
- General safety baseline: full blood count and a metabolic panel before starting anything, which also catches the anaemia and thyroid problems that were causing your symptoms in the first place.
Three practical points. Test before you start, or the follow-up has nothing to compare against. Use the same laboratory, because reference ranges and assay methods differ. And hold your conditions steady — IGF-1 in particular responds to protein intake, exercise and stress, so a result taken during a hard training block or a diet is not comparable to one taken at rest.
Decide the Verdict in Advance
Write down, before your first dose, what would make you continue and what would make you stop. This takes five minutes and it is the difference between an experiment and a habit.
A workable version has three parts: the metric, the threshold, and the date. "If my weekly average waist measurement has not moved by at least 2 cm by week ten, I stop." "If my deep-work minutes have not improved by 20% by week four, I stop." The specific numbers matter less than having committed to them while you were still neutral.
Without this, the goalposts move. Nothing happened at week four, so you extend to week eight. Nothing at week eight, so perhaps the dose. This is the mechanism by which people run something for a year — see our page on common beginner mistakes, where chasing the dose is the entry that follows directly from having no stopping rule.
A Tracking Template
Fifteen seconds a day. A notebook works as well as an app, and a spreadsheet is better than both because it will calculate your averages.
| Column | What goes in it | Why |
|---|---|---|
| Date | Every day, including days you dosed nothing | Gaps are data; you need to see them |
| Compound and amount | What you took, and the site if injecting | Catches the pattern where one site always stings |
| Primary metric | The one number your decision rule depends on | This is the column that answers the question |
| Secondary metric | One or two supporting measures | Enough for context, few enough to sustain |
| Anything noticed | Side effects, sleep, mood — a few words | Turns "I felt off in March" into a date |
| Confounders | Illness, travel, a hard week, alcohol, a new supplement | The column that explains your weird results |
Then, weekly, add one row that averages the primary metric. The weekly row is what you will actually make decisions from; the daily rows exist to feed it.
Keep tracking in proportion
Measurement is a tool for making one decision, not an activity in itself. If daily weighing makes you anxious, or you find yourself checking numbers more than you think about the thing they represent, switch to weekly measurements or drop to non-scale metrics like how clothes fit and what you can lift. A protocol you can evaluate is worth more than a spreadsheet you dread, and no amount of data is worth a worse relationship with food or your body. If tracking is pulling in that direction, that is a good reason to talk to a healthcare professional rather than to track harder.
Reading Your Own Data
Four failure modes to watch for once you have numbers in front of you.
Reading the first week
Week one reflects novelty, attention and whatever you changed alongside. Judge from week three onward.
Finding the story you wanted
With enough metrics, one will always be moving. If you switch to whichever measure looks best, you have stopped measuring and started narrating.
Ignoring the confounder column
You started a compound and also started sleeping properly. Both are in the data. Only one is on the label.
Treating a flat line as failure
If the goal was preventing a decline, no change is the result. Decide which direction counts as success before you look.
One genuinely useful test if a result is ambiguous: stop for a few weeks and keep measuring. If the effect was real, it should recede — and if it recedes and returns when you restart, that is the strongest evidence a single person can generate about themselves.
Common Questions
How long should I track before deciding?
Long enough for the metric you chose to be capable of moving — which is the point of the timescale table above. For a subjective rating, three to four weeks. For a weight trend, six to eight. For body composition or HbA1c, months. Deciding earlier is not a decision, it is a guess.
Are wearables and smart rings good enough?
For trends in the same person over time, they are useful — consistent measurement error mostly cancels out when you are comparing yourself to yourself. For absolute accuracy, particularly sleep staging, they are considerably less reliable than the marketing implies. Use the direction of travel, not the specific number.
Do I really need bloodwork?
For anything acting on hormones or glucose, it is the only way to see what is happening — and the safety information it provides is arguably more valuable than the efficacy information. Testing in Costa Rica is generally more accessible than people expect, and our FAQ page covers the local side of things. If it genuinely is not possible, be considerably more conservative about those compound classes rather than proceeding blind.
Should I track if I'm running more than one compound?
Track, yes — but understand what the data can tell you. With two compounds started together, any result belongs to the combination, not to either one. If you want to know which is doing the work, they have to be introduced separately with enough time between them for the first to show its effect.
What if I feel great but the numbers say nothing?
Worth taking seriously rather than dismissing, especially where the goal is a felt outcome like sleep or pain — in those cases the feeling is the endpoint. Where the goal was a measurable change, though, feeling good while the metric is flat is exactly what expectation produces, and it is the situation the stop-for-a-few-weeks test was designed for.
Can I compare my results to other people's?
Not usefully. Responses vary widely, protocols differ, and what gets posted online is heavily filtered toward people who saw something happen. Your own baseline is the only honest comparison you have.
How many metrics should I track?
One primary and one or two secondary. More than that and you will stop doing it by week three, and you increase the odds that something moves by chance and gets mistaken for a result.
What if my bloodwork comes back abnormal?
Take it to a doctor rather than to a forum — our page on when to consult a doctor covers the thresholds — and take your tracking log with you — it turns "I've been taking something" into a dated record of what and when. That is genuinely useful clinical information and it is one of the underrated benefits of keeping one.
Not sure what to measure?
Tell us what you're running and what you're hoping to change, and we'll suggest what would actually show it — including when the honest answer is that you'd need bloodwork to know.
Contact Us on WhatsAppImportant disclaimer: The information in this guide is general educational content only. It is not medical advice, a prescription, or a personalized recommendation. No dosing figures appear on this page by design. The laboratory tests described are a general account of what clinicians commonly monitor in the contexts mentioned; they are not a recommendation that any individual should undergo any particular test, and decisions about which investigations are appropriate should be made with a qualified healthcare professional who knows your medical history. Interpretation of blood results requires clinical context, and reference ranges vary between laboratories and assay methods. Most peptides sold by Peptides Costa Rica are not approved by the FDA, the EMA, or Costa Rica's Ministerio de Salud as finished pharmaceutical drugs for human use and are sold as research compounds intended for laboratory and scientific study; tracking a response does not establish that a compound is safe or effective. Self-tracking of a single individual cannot establish cause and effect, and apparent improvements may reflect expectation, natural variation, regression to the mean, or concurrent changes in diet, training, sleep or other factors. Persistent symptoms should be investigated medically rather than monitored indefinitely. If tracking measurements is causing anxiety or contributing to a difficult relationship with food, eating or body image, that is a reason to seek support from a qualified professional. Always consult a qualified healthcare professional before beginning or adjusting any peptide protocol. Products sold by Peptides Costa Rica are intended for laboratory and research purposes only.
- American Association of Clinical Endocrinologists and American College of Endocrinology guidelines: Recommendation to use serum IGF-1 as the biomarker guiding growth hormone dose adjustments, individualising dose and titrating from a low starting point to normalise IGF-1 within the age-adjusted reference range.
- Clinical endocrinology literature on IGF-1 monitoring: Growth hormone is secreted in pulses and fluctuates with food, stress, exercise and sleep, making single GH measurements unreliable; IGF-1 is more stable and reflects average GH activity.
- Journal of Clinical Endocrinology & Metabolism (Kildemoes et al., 2020; Bidlingmaier & Schilbach, 2021): With longer-acting formulations, the day of sampling relative to dosing materially changes the IGF-1 reading, and reliable interpretation requires sampling at steady state and at a consistent point in the interval.
- Growth hormone therapy monitoring practice: Monitoring typically combines clinical assessment with IGF-1, fasting glucose, thyroid function and lipid profile at defined intervals.
- Reference literature on IGF-1 determinants: IGF-1 is sensitive to protein and caloric intake, exercise, glucocorticoids and stress, all of which confound comparison between samples taken under different conditions.
- Clinical guidance on body weight variability: Adult body weight commonly fluctuates by approximately 1 to 2 kg over days to weeks from fluid balance, glycogen, food volume and elimination, supporting consistent same-time measurement and comparison of averages rather than individual readings.
